{
  "_id": "4e4d36fa7d8bd49b61d1d65ca0b34afac282bf3e49215d1073e2acdf335edf75",
  "feed": "market-watch",
  "title": "Dow tumbles over 600 points as omicron fears ignite fresh selling to start abbreviated Christmas week",
  "text": "<p>How are stock indexes trading?</p><p>The S&amp;P 500 SPX traded 84 points, or 1.8%, lower at 4,535.</p><p>The Dow Jones Industrial Average DJIA fell 676 points, or 1.9%, to around 34,688, weighed by losses in UnitedHealth Group Inc., UNHTravelers Cos. Inc.TRV, Caterpillar Inc. CAT, and Goldman SachsGroup Inc. GS.</p><p>The Nasdaq Composite Index COMP declined 296 points, or 2%, to reach 14,874, putting the tech-heavy index more than 7% below its Nov. 19 record close.</p><p>On Friday, the Dow dropped more than 500 points, or 1.5%, with the S&amp;P 500 and Nasdaq Composite following it lower. For the week, the Dow lost 1.7%, the S&amp;P 500 dropped 1.9% and the Nasdaq tumbled 3%.</p><p>What's driving the markets?</p><p>Markets were slumping in the start to an abbreviated week of trading for most financial markets in observance of Christmas. All 11 sectors of the S&amp;P 500 were trading in negative territory, led by sharp declines in financials XX:SP500.40, materials XX:SP500.15, and consumer-discretionary stocks XX:SP500.25 as crude prices plunged.</p><p>Worries about omicron have sapped some of the joy out of the market for bullish investors, with lockdowns in parts of Europe weighing on sentiment.</p><p>News that President Joe Biden's signature $2 trillion spending plan appeared doomed also was being greeted with selling. Sen. Joe Manchin, D-W.Va., said on Sunday that he cannot support it—potentially handing Biden and Democrats a major political loss.</p><p>Prompted by the political wrangling, a team led by Jan Hatzius, chief U.S. economist for Goldman Sachs, downgraded its U.S. growth forecast for 2022, citing difficulties in getting the spending bill passed. Declines in all three major stock-market indexes followed losses last week, which came as Federal Reserve officials sped up their reduction of monthly bond purchases and penciled in three interest-rate hikes next year.“If worries about the spread of Omicron abated, stock markets would probably recover some of the ground they've lost recently,” said Thomas Mathews, markets economist for Capital Economics. “But given the prospect of less supportive monetary and fiscal policy, and how far equities have already come, we wouldn't expect this to mark the beginning of another sustained rally, either,” Mathews wrote in a note. “Instead, we expect fairly underwhelming returns from equities over the next couple of years.”</p><p>Need to know: These are the big levels to watch for the S&amp;P 500 and Nasdaq. Expect ‘wild trade,' if they break, warns this strategist.</p><p>Early Monday, ModernaMRNA said its COVID-19 booster, when combined with two vaccines, offers 37-fold protection against the omicron variant.</p><p>That is as new COVID-19 cases are growing sharply in many parts of the world, fueled by the rapid spread of that variant. Dr. Anthony Fauci said Sunday that he expects record cases of COVID-19 this winter, and urged people to get vaccinated and get boosters. The Netherlands began a lockdown that will last until mid-January and the U.K. hasn't ruled out tighter pre-Christmas restrictions.</p><p>Meanwhile, the World Economic Forum announced that its annual meeting in Davos, Switzerland, which was due to be held in January, will be delayed to summer 2022, due to the spread of COVID-19. It's the second straight year that the conference has been postponed.</p><p>Read:Cathie Wood says stocks have corrected into ‘deep value territory' and won't let benchmarks ‘hold our strategies hostage'</p><p>Selling of perceived riskier assets extended to oil prices, which fell sharply on concerns of a growing hit to the global economy. Front-month West Texas intermediate crude CL. 1 fell 5% to $67.32 a barrel, while Brent crude BRN00, the global benchmark, dropped 4.4% to $70.30 a barrel.</p><p>On the data front, the U.S. leading economic index rose a sharp 1.1% in November, the Conference Board said Monday. Economists polled by The Wall Street Journal had expected a 0.9% gain. Over the last six months, the index is up 4.6%.</p><p>The increase signals the economy will continue to expand in the first half of 2022 although the resurgence of COVID-19, inflation and supply-chain disruptions remain risks, said Ataman Ozyildirim, senior director of economic research at the Conference Board.&#xa0;</p><p>Which companies are in focus?</p><p>Oracle Corp.&#xa0;ORCL confirmed on Monday a deal to acquire electronic-medical-records company Cerner Corp.&#xa0;CERN&#xa0;for $95 a share. Oracle shares were down 4.9%, while Cerner shares were up 1%.</p><p>Shares of BP Midstream PartnersBPMP surged 13% after energy giant BP BP said it has entered into a definitive agreement to buy the master limited&#xa0;partnership in an all stock-deal. BP Midstream shares rose almost 13%.</p><p>Novavax shares NVAX were down 7.7%, even after the European Medicines Agency recommended granting conditional marketing authorization for its COVID-19 vaccine.</p><p>Moderna MRNA shares fell 5% even after the pharmaceutical group said a booster shot of its COVID-19 vaccine provided 37-fold protection against the omicron variant when combined with two vaccine shots.</p><p>BiogenBIIB shares slipped 1.1%, as the biotechnology company said it would cut the price of its Alzheimer's drug Aduhlem by roughly 50%, to about $28,200 a year, starting Jan. 1.</p><p>Bluebird BioBLUE shares tumbled 10% after the company announced a partial clinical hold for patients under 18 in its sickle cell gene therapy program.</p><p>How are other assets trading?</p><p>The yield on the 10-year Treasury note BX:TMUBMUSD10Y fell less than 1 basis points to 1.4%, according to Dow Jones Market Data. Treasury yields and prices move in opposite directions.</p><p>The ICE U.S. Dollar Index&#xa0;DXY,&#xa0;a measure of the currency against a half-dozen other monetary units, was down under 0.1%.</p><p>Gold futures&#xa0;GC00&#xa0;for February delivery&#xa0;GCG22 fell 0.6% to trade at $1,794.50 an ounce.</p><p>The Stoxx Europe 600 Index&#xa0;XX:SXXP closed 1.4% lower, while&#xa0;London's FTSE 100 index UK:UKX finished down by 1%.</p><p>In Asia, the Shanghai Composite Index&#xa0;CN:SHCOMP&#xa0;finished 1% lower and the Hang Seng Index&#xa0;HK:HSI closed down by 1.9% in Hong Kong. Meanwhile, China's CSI 300&#xa0;XX:000300 finished 1.5% lower and Japan's Nikkei 225 Index&#xa0;JP:NIK closed down by 2.1%.</p><p>— Barbara Kollmeyer contributed to this article</p>",
  "published": "2021-12-20T13:11:00.000Z",
  "tags": [
    {
      "id": "US91324P1021",
      "nexusId": "10018613",
      "name": "UnitedHealth Group Incorporated",
      "offsets": [
        {
          "start": 193,
          "end": 216
        }
      ]
    }
  ]
}